跳至主要内容
临床试验/NCT00622882
NCT00622882Unknown不适用

Early Infectious Disease Consultation for Better Outcomes From Staphylococcus Aureus Bacteremia

National University Hospital, Singapore2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
2
主要终点
mortality

研究概览

简要总结

The primary objective is to determine if early infectious disease (ID) consultation (defined as within 48 hours of a positive blood culture) will reduce mortality rates from Staphylococcus aureus bacteremia (SAB). This study will also determine if such consultations could reduce the duration of hospitalisation, recurrence and financial costs in patients with this infection.

详细描述

Bacteremia is a serious manifestation of Staphylococcus aureus infection with an attributable mortality as high as 25% in MRSA bacteremia. More than a third of patients end up with complications such as endocarditis, osteomyelitis or pneumonia.

Overall the outcome of patients with respect to mortality or recurrence is better in patients who have an eradicable focus and have received an appropriate antibiotic dose and duration. Also complicated bacteremia is more common in patients with

  • persistent bacteremia or fever
  • prosthetic device
  • new murmur
  • skin findings of a systemic infection

Based on this evidence, an ID consultation could improve the outcomes of patients with SAB by

  • Advising adequate antibiotic dosage and duration
  • Sourcing out and counselling eradication of any focus of infection

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
1 Month 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All inpatients at the National University Hospital with Staphylococcus aureus (both methicillin sensitive and methicillin resistant) bacteremia isolated within the defined time period

排除标准

  • Patients who died or were discharged before the notification from the laboratory
  • Polymicrobial bacteremia

结局指标

主要结局

mortality

时间窗: 1 year

次要结局

  • recurrence(2 year)
  • duration of hospitalisation(1 year)
  • financial costs of hospitalisation(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Medicine

Professor Paul Ananth Tambyah

National University Hospital, Singapore

研究点 (2)

Loading locations...

相似试验